News & Publications

Risk Associated Breast Lesions Core Needle Biopsy

By Hongxiu Ji, MD, PhD

A palpable or imaging-detected breast lesion is often first evaluated by core needle biopsy (CNB) under ultrasound, stereotactic or MRI guidance. The pathology can be divided into three categories: benign, malignant and risk-associated breast lesions.

Read more…

The Milan System for Reporting Salivary Gland Cytopathology

By Liqun Yin, MD

Salivary gland cytology presents many diagnostic challenges. Salivary gland tumors are one of the most heterogeneous groups of neoplasms, and salivary gland tumors are one of the most difficult areas of evaluation in cytology. The FNA sensitivity is between 86-100% with specificity somewhere between 48-94%.

Read more…

ICD-10: Coding Gynecological Specimens for Laboratory

By Tiris Mjelde

 The practice of medicine has changed dramatically in the last 25 years or so. New conditions have been discovered and many new treatments and medical devices have been developed. The ICD-10 code set that became effective on October 1, 2015, tries to capture the current practice of medicine and provide flexibility as it changes in the future.

Read more…

Incyte Diagnostics and Blue Mountain Pathology Announce Acquisition

Spokane, WA and Pendleton, OR—Incyte Diagnostics based in Spokane, Bellevue, Walla Walla and Yakima, WA and Blue Mountain Pathology based in Pendleton, OR have entered into a letter of intent to combine their two pathology practices. This transaction will create a regional pathology practice where physicians and hospitals can access 47 board certified pathologists with expertise in 27 disciplines/subspecialties.

Read more…